Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
53.60
+0.86 (1.63%)
Dec 20, 2024, 4:00 PM EST - Market closed
Crinetics Pharmaceuticals Employees
Crinetics Pharmaceuticals had 290 employees as of December 31, 2023. The number of employees increased by 80 or 38.10% compared to the previous year.
Employees
290
Change (1Y)
80
Growth (1Y)
38.10%
Revenue / Employee
$3,583
Profits / Employee
-$958,310
Market Cap
4.97B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Integer Holdings | 10,500 |
RadNet | 8,441 |
Alkermes | 2,100 |
Tempus AI | 1,952 |
BridgeBio Pharma | 556 |
Corcept Therapeutics | 352 |
TG Therapeutics | 264 |
Krystal Biotech | 229 |
CRNX News
- 11 days ago - Crinetics Pharmaceuticals Announces December 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 12 days ago - Crinetics Announces FDA Acceptance of New Drug Application for Paltusotine for Adult Patients with Acromegaly - GlobeNewsWire
- 5 weeks ago - UPDATE: Crinetics Pharmaceuticals to Showcase Pipeline Advancements with Neuroendocrine Tumor Candidates at The North American Neuroendocrine Tumor Society (NANETS) Annual Meeting - GlobeNewsWire
- 5 weeks ago - Crinetics Pharmaceuticals, Inc. (CRNX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Crinetics Pharmaceuticals to Showcase Pipeline Advancements with Neuroendocrine Tumor Candidates at The North American Neuroendocrine Tumor Society (NANETS) Annual Meeting - GlobeNewsWire
- 5 weeks ago - Crinetics Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 5 weeks ago - Crinetics Pharmaceuticals Announces November 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Crinetics Pharmaceuticals Announces October 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire